Reiterates Neutral News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Reiterates neutral. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Reiterates Neutral Today - Breaking & Trending Today

Cautious Optimism Surrounds Dollar General's FY24: Analysts Highlight Strategic Gains Amid Emerging Risks - Dollar Gen (NYSE:DG)

Cautious Optimism Surrounds Dollar General's FY24: Analysts Highlight Strategic Gains Amid Emerging Risks - Dollar Gen (NYSE:DG)
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Joseph Feldman , Scot Ciccararelli , Telsey Advisory Group , Reiterates Hold , Dollar General , Reiterates Market Perform , Kelly Bania , Advisory Group , Reiterates Outperform , Reiterates Neutral ,

Analysts Highlight Target's Market Share Struggles And Increased Competition: Details - Target (NYSE:TGT)

BMO Capital's Kelly Bania reiterates Market Perform for Target but lowers the price target from $170 to $155. Despite 1Q results meeting expectations, concerns arise over continued gross margin upside, share losses in food and consumables, and competition from Amazon and Walmart. ....

Walmart Inc , Steven Shemesh , Scot Ciccarelli , Target Corp , Reiterates Market Perform , Kelly Bania , Target Blames , Strain On Consumer Wallet For Tough , Reiterated Outperform , Reiterates Neutral , Reiterates Hold , Great Recession , Consumer Staples Select Sector , Vanguard Consumer Staples , Sales Decline And , Why Analysts Remain ,

Coca-Cola's Refreshing Results: Analysts Bullish Despite Near-Term Concerns - Coca-Cola (NYSE:KO)

Goldman Sachs maintains a Neutral rating on KO with a $60.00 price target. Analyst Bonnie Herzog highlights KO's robust Q1 organic revenue growth of 11%, exceeding expectations. Despite this, limited EPS growth potential might weigh on the stock in the near term, notes the analyst. Truist and BofA Securities analysts reiterate Buy rating. ....

United States , Cola Co , Bonnie Herzog , Bryand Spillane , Vanguard Total Stock Market Index Fund , Goldman Sachs , Reiterates Neutral , North American , Reiterates Buy , North America , Bill Chappell ,

Potential Label Restrictions Loom For Alnylam's Patisiran Despite Approval Prospects - Alnylam Pharmaceuticals (NASDAQ:ALNY)

On Wednesday, an FDA advisory committee voted 9-3 in favor of Alnylam Pharmaceuticals Inc's (NASDAQ: ALNY) patisiran. ....

Renal Drugs Advisory Committee , Alnylam Pharmaceuticals Inc , Prescription Drug User Fee , William Blair , Reiterates Neutral ,